Carl Zeiss Meditec AG with its subsidiaries is one of the world’s leading medical technology companies. The company offers complete solutions to diagnose and treat ophthalmic diseases. In the field of microsurgery the company provides innovative visualization solutions.
Our portfolio is rounded off by promising future-oriented technologies such as intraoperative radiotherapy.
|Owners:||The Carl Zeiss Meditec AG is listed on the TecDAX of the German stock exchange (ISIN DE 0005313704); 65 percent of the shares are held by Carl Zeiss AG. The remaining shares are in free float.|
|Locations:||Besides its headquarters in Jena/ Germany, the Carl Zeiss Meditec has subsidiaries in the USA, Japan, Germany, Spain, France, Turkey and UK. Additional ZEISS Research and Development Centers in India and China strengthen the company's presence in these rapidly developing economies. In other countries the company makes use of the vaste distribution network of ZEISS.|
|Board:||• Dr. Ludwin Monz (President and CEO)
• Dr. Christian Müller
|Revenue:||In fiscal year 2015/16, €1,088.4 million*|
|Employees:||The Carl Zeiss Meditec Group has about 2,900 employees worldwide, including around 400 at the headquarters in Jena (as of September 30, 2016).*|
* Revenue and number of employees deviate from the published figures of the Medical Technology business group of ZEISS Group as a result of different consolidation models.